- Market Realist•48 minutes ago
On January 26, 2006, the FDA approved Pfizer's (PFE) Sutent as a therapy for patients suffering from GIST (gastrointestinal stromal tumors).
- Forbes•17 hours ago
Lynn Seely, the CEO of Myovant Sciences, talks to Forbes about the company she just led onto the New York Stock Exchange.
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||32.55 x 400|
|Ask||32.68 x 500|
|Day's Range||32.37 - 32.81|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||28.79|
|Avg Vol (3m)||19,193,012|
|Dividend & Yield||1.20 (3.70%)|